Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 3, 2025Clinical Pharmacology & TherapeuticsOpen Access

Selecting and Preparing Clinical Sites for the Successful Conduct of Decentralized Clinical Trial Activities–Findings From the Trials@Home RADIAL Proof‐of‐Concept Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

KLKatarzyna LipinskaDWDanny van WeelijBLBart Lagerwaard

Discussion

Loading...

Member takes

Overview

Multicenter phase IV trial revealed challenges in site selection and technology management for decentralized clinical trials.

Key Points

  • Decentralized clinical trials improve accessibility and efficiency, yet operational challenges remain for sites.
  • Phase IV trial comparing conventional and decentralized methods included six countries for type 2 diabetes management.
  • Detailed assessments of site capabilities were critical for selecting clinical sites and ensuring successful trial conduction.
  • Continuous support and training were essential to navigate complexities related to technology and contractual agreements.

Cite This Study

Lipinska et al. (2025) studied this question.

synapsesocial.com/papers/68e034f7f0e39f13e7fa32dfhttps://doi.org/10.1002/cpt.70075
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bringing Trial Activities to Participants—The Trials@Home <scp>RADIAL</scp> Proof‐of‐Concept Trial Investigating Decentralization of Trials2025 · 8 citations
  2. 2Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative2019 · 114 citations
  3. 3Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learned2023 · 51 citations
  4. 4Clinical trial site readiness for decentralized trials – fitting trials into today’s world2024 · 2 citations
  5. 5Adoption of Decentralized Trial Elements in Cancer Clinical Trials Supporting FDA Approvals during COVID-192025 · 7 citations